HSIL
Hemant Surgical Industries financials
- Market cap
- ₹532 Cr
Quarterly results
Q4 FY26: revenue up 187.9%, net profit up 116.7% against the same quarter last year.
| Line item | Q2 FY23 | Q4 FY23 | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 51 | 58 | 48 | 58 | 49 −4% | 58 +0% | 65 +35% | 167 +188% |
| EBITDA | 4 | 6 | 3 | 7 | 4 +0% | 5 −17% | 8 +167% | 16 +129% |
| Net profit | 2 | 5 | 4 | 6 | 3 +50% | 5 +0% | 5 +25% | 13 +117% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +43.8% 1Y
1Y: ₹326.8 on 10 Sept 2025 → ₹470. High ₹483 (8 Sept 2026), low ₹217.5 (30 Mar 2026).
Balance sheet
| Year ending | FY25 | FY26 |
|---|---|---|
| Equity capital | ₹13 Cr | ₹13 Cr |
| Reserves | ₹110 Cr | ₹125 Cr |
| Borrowings | ₹53 Cr | ₹50 Cr |
| Other liabilities | ₹39 Cr | ₹87 Cr |
| Total liabilities | ₹215 Cr | ₹274 Cr |
| Fixed assets | ₹34 Cr | ₹53 Cr |
| Capital work in progress | ₹17 Cr | ₹0 Cr |
| Investments | ₹3 Cr | ₹0 Cr |
| Other assets | ₹161 Cr | ₹221 Cr |
| Total assets | ₹215 Cr | ₹274 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at May 2026
Since Mar 2025, promoters trimmed −20.73 pp while DIIs added +18.83 pp. The shareholder count shrank 23% to 948.
- Promoters
- 52.8%
- FIIs
- 0.1%
- DIIs
- 19.9%
- Public
- 27.1%
Since Mar 2025
- Promoters −20.73 pp
- DIIs +18.83 pp
- Public +2.17 pp
How it drifted, 7 quarters
Over this window promoters fell from 73.6% to 52.8% — −20.7 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 73.6%, FIIs 0.0%, DIIs 4.3%, Public 22.1%.Mar '24: Promoters 73.6%, DIIs 2.0%, Public 24.5%.Sep '24: Promoters 73.6%, DIIs 1.1%, Public 25.3%.Mar '25: Promoters 73.6%, FIIs 0.4%, DIIs 1.1%, Public 24.9%.Sep '25: Promoters 58.9%, FIIs 0.1%, DIIs 10.8%, Public 30.1%.Mar '26: Promoters 58.9%, FIIs 0.1%, DIIs 10.7%, Public 30.2%.May '26: Promoters 52.8%, FIIs 0.1%, DIIs 19.9%, Public 27.1%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Singularity Equity Fund I AIF +4.28 pp 6.19% held
- Singularity Large Value Fund Iii VC / PE +4.28 pp 6.19% held
- Singularity Equity Fund Ii VC / PE newly disclosed 1.38% held
The same filing shows 12 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the May 2026 filing
Every holder of Hemant Surgical Industries Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Hanskumar Shamji Shah | 24.26% | −2.79 pp |
| Kaushik Hanskumar Shah | 14.47% | −1.66 pp |
| Hemant Praful Shah | 11.93% | −1.37 pp |
| Singularity Equity Fund I AIF | 6.19% | +4.28 pp |
| Singularity Large Value Fund Iii VC / PE | 6.19% | +4.28 pp |
| Singularity Large Value Fund I VC / PE | 3.44% | −0.39 pp |
| Wealthwave Capital Trust-Wealthwave Capital Fund AIF | 2.75% | −0.32 pp |
| Mona Laroia | 2.32% | −0.25 pp |
| Swati Pokharna | 2.06% | −0.24 pp |
| Renu Devi Hisaria | 2.06% | −0.24 pp |
| Bimla Bajaj | 1.38% | −0.15 pp |
| Singularity Equity Fund Ii VC / PE | 1.38% | newly disclosed |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Hemant Surgical Industries Limited
Guides on how to read this kind of business and the numbers that matter.